BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 15942625)

  • 21. Rare variants in the ATM gene and risk of breast cancer.
    Goldgar DE; Healey S; Dowty JG; Da Silva L; Chen X; Spurdle AB; Terry MB; Daly MJ; Buys SM; Southey MC; Andrulis I; John EM; ; ; Khanna KK; Hopper JL; Oefner PJ; Lakhani S; Chenevix-Trench G
    Breast Cancer Res; 2011 Jul; 13(4):R73. PubMed ID: 21787400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Severe reaction to radiotherapy for breast cancer as the presenting feature of ataxia telangiectasia.
    Byrd PJ; Srinivasan V; Last JI; Smith A; Biggs P; Carney EF; Exley A; Abson C; Stewart GS; Izatt L; Taylor AM
    Br J Cancer; 2012 Jan; 106(2):262-8. PubMed ID: 22146522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ATM and genome maintenance: defining its role in breast cancer susceptibility.
    Khanna KK; Chenevix-Trench G
    J Mammary Gland Biol Neoplasia; 2004 Jul; 9(3):247-62. PubMed ID: 15557798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of ATM mutations in 41 Nordic families with ataxia telangiectasia.
    Laake K; Jansen L; Hahnemann JM; Brondum-Nielsen K; Lönnqvist T; Kääriäinen H; Sankila R; Lähdesmäki A; Hammarström L; Yuen J; Tretli S; Heiberg A; Olsen JH; Tucker M; Kleinerman R; Børresen-Dale AL
    Hum Mutat; 2000 Sep; 16(3):232-46. PubMed ID: 10980530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p53 centrosomal localization diagnoses ataxia-telangiectasia homozygotes and heterozygotes.
    Prodosmo A; De Amicis A; Nisticò C; Gabriele M; Di Rocco G; Monteonofrio L; Piane M; Cundari E; Chessa L; Soddu S
    J Clin Invest; 2013 Mar; 123(3):1335-42. PubMed ID: 23454770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel mutation in the ATM gene in a Malian family with ataxia telangiectasia.
    Landouré G; Mochel F; Meilleur K; Ly M; Sangaré M; Bocoum N; Bagayoko K; Coulibaly T; Sarr AM; Bâ HO; Coulibaly S; Guinto CO; Touré M; Traoré M; Fischbeck KH
    J Neurol; 2013 Jan; 260(1):324-6. PubMed ID: 23142947
    [No Abstract]   [Full Text] [Related]  

  • 27. Health risks for ataxia-telangiectasia mutated heterozygotes: a systematic review, meta-analysis and evidence-based guideline.
    van Os NJ; Roeleveld N; Weemaes CM; Jongmans MC; Janssens GO; Taylor AM; Hoogerbrugge N; Willemsen MA
    Clin Genet; 2016 Aug; 90(2):105-17. PubMed ID: 26662178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The genetic epidemiology of breast cancer genes.
    Thompson D; Easton D
    J Mammary Gland Biol Neoplasia; 2004 Jul; 9(3):221-36. PubMed ID: 15557796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dominant negative ATM mutations in breast cancer families.
    Chenevix-Trench G; Spurdle AB; Gatei M; Kelly H; Marsh A; Chen X; Donn K; Cummings M; Nyholt D; Jenkins MA; Scott C; Pupo GM; Dörk T; Bendix R; Kirk J; Tucker K; McCredie MR; Hopper JL; Sambrook J; Mann GJ; Khanna KK
    J Natl Cancer Inst; 2002 Feb; 94(3):205-15. PubMed ID: 11830610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The ATM gene and ataxia telangiectasia.
    Mavrou A; Tsangaris GT; Roma E; Kolialexi A
    Anticancer Res; 2008; 28(1B):401-5. PubMed ID: 18383876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contribution of mutations in ATM to breast cancer development in the Czech population.
    Soukupova J; Dundr P; Kleibl Z; Pohlreich P
    Oncol Rep; 2008 Jun; 19(6):1505-10. PubMed ID: 18497957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphoid tumours and breast cancer in ataxia telangiectasia; substantial protective effect of residual ATM kinase activity against childhood tumours.
    Reiman A; Srinivasan V; Barone G; Last JI; Wootton LL; Davies EG; Verhagen MM; Willemsen MA; Weemaes CM; Byrd PJ; Izatt L; Easton DF; Thompson DJ; Taylor AM
    Br J Cancer; 2011 Aug; 105(4):586-91. PubMed ID: 21792198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Homozygosity for c 6325T>G transition in the ATM gene causes an atypical, late-onset variant form of ataxia-telangiectasia.
    Silvestri G; Masciullo M; Piane M; Savio C; Modoni A; Santoro M; Chessa L
    J Neurol; 2010 Oct; 257(10):1738-40. PubMed ID: 20480175
    [No Abstract]   [Full Text] [Related]  

  • 34. New mutations in the ATM gene and clinical data of 25 AT patients.
    Demuth I; Dutrannoy V; Marques W; Neitzel H; Schindler D; Dimova PS; Chrzanowska KH; Bojinova V; Gregorek H; Graul-Neumann LM; von Moers A; Schulze I; Nicke M; Bora E; Cankaya T; Oláh É; Kiss C; Bessenyei B; Szakszon K; Gruber-Sedlmayr U; Kroisel PM; Sodia S; Goecke TO; Dörk T; Digweed M; Sperling K; de Sá J; Lourenco CM; Varon R
    Neurogenetics; 2011 Nov; 12(4):273-82. PubMed ID: 21965147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence of cancer in 161 families affected by ataxia-telangiectasia.
    Swift M; Morrell D; Massey RB; Chase CL
    N Engl J Med; 1991 Dec; 325(26):1831-6. PubMed ID: 1961222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study.
    Bernstein JL; Haile RW; Stovall M; Boice JD; Shore RE; Langholz B; Thomas DC; Bernstein L; Lynch CF; Olsen JH; Malone KE; Mellemkjaer L; Borresen-Dale AL; Rosenstein BS; Teraoka SN; Diep AT; Smith SA; Capanu M; Reiner AS; Liang X; Gatti RA; Concannon P;
    J Natl Cancer Inst; 2010 Apr; 102(7):475-83. PubMed ID: 20305132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunodeficiency in ataxia telangiectasia is correlated strongly with the presence of two null mutations in the ataxia telangiectasia mutated gene.
    Staples ER; McDermott EM; Reiman A; Byrd PJ; Ritchie S; Taylor AM; Davies EG
    Clin Exp Immunol; 2008 Aug; 153(2):214-20. PubMed ID: 18505428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ATM mutations in cancer families.
    Vorechovský I; Luo L; Lindblom A; Negrini M; Webster AD; Croce CM; Hammarström L
    Cancer Res; 1996 Sep; 56(18):4130-3. PubMed ID: 8797579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ATM haplotypes and associated mutations in Iranian patients with ataxia-telangiectasia: recurring homozygosity without a founder haplotype.
    Babaei M; Mitui M; Olson ER; Gatti RA
    Hum Genet; 2005 Jul; 117(2-3):101-6. PubMed ID: 15843990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of breast cancer and other cancers in heterozygotes for ataxia-telangiectasia.
    Inskip HM; Kinlen LJ; Taylor AM; Woods CG; Arlett CF
    Br J Cancer; 1999 Mar; 79(7-8):1304-7. PubMed ID: 10098776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.